2D-BioPAD aims to introduce a fast and cost-effective, non-invasive, reliable, digitally and graphene enabled Point-of-Care (PoC) in-vitro diagnostics (IVD) system for supporting the early diagnosis and progression monitoring of Alzheimer’s Disease (AD) directly at primary healthcare settings. To achieve this, and tackle the scientific challenge, the technological and market gap of PoC IVD for AD, 2D-BioPAD leverages the unique properties of 2D materials, such as graphene and its derivatives.
Apr 2024 2nd newsletter
Mar 2024 YouTube Video
Jan 2024 1st newsletter
